GlassScriptPhysician profile
Dustin T Simcoe
NPI 1295108942
$588.60
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $60.61 · 2023: $182 · 2024: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $99.29 | 2021-2024 | Wegovy |
| Mylan Specialty L.P. | $93.11 | 2023-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.32 | 2021-2023 | Jardiance, Tradjenta, Stiolto Respimat |
| Merck Sharp & Dohme LLC | $64.97 | 2021-2023 | Steglatro, Belsomra |
| Shield Therapeutics INC | $52.84 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $34.40 | 2024 | Airsupra, Breztri |
| Idorsia Pharmaceuticals US INC | $31.31 | 2022-2023 | Quviviq |
| Lilly USA, LLC | $29.47 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.80 | 2021 | |
| Abbvie INC. | $22.92 | 2024 | |
| Edwards Lifesciences Corporation | $18.82 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Dexcom, INC. | $17.71 | 2023 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $14.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Simcoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.